Clinical Trial Update: A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating EMB 001 for cocaine use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• EMB-001 (Metyrapone/Oxazepam combination)

Snippet

Sponsor: Embera NeuroTherapeutics, Inc. | Conditions: Cocaine Use Disorder | Phase 2 | Status: COMPLETED